Mobidiag

29/09/2021

From today, we will no longer be actively posting or monitoring this page. If you want to see what we do next, follow Hologic. Thank you for being part of our journey so far!

Tästä päivästä lähtien emme enää aktiivisesti viesti tämän kanavan kautta. Seuraathan jatkossa viestintäämme Hologic kautta. Kiitos kaikille matkassamme mukana olleille!

À ce jour, nous ne publierons plus et cesserons toute activité sur cette page. Si vous souhaitez en savoir plus, suivez Hologic. Merci d'avoir fait partie de notre aventure !

22/09/2021

Ces derniers mois, nos équipes ont appris à connaître et ont renforcé leurs liens avec leurs nouveaux collègues chez Hologic. Au cours de notre intégration dans l'entreprise, nous avons pris la décision de cesser notre communication sur les réseaux sociaux en tant que Mobidiag.
Merci à tous ceux qui nous ont accompagné dans notre aventure jusqu'à présent. Ce fut incroyable ! Et nous aimerions continuer à la partager avec vous. N'hésitez donc pas à suivre la page Facebook Hologic

22/09/2021

Viime kuukausien aikana olemme saaneet tutustua uusiin kollegoihimme Hologicilla. Yhdistymisen edetessä olemme tehneet päätöksen lopettaa viestintämme Mobidiagin sosiaalisen median kanavissa.
Kiitos kaikille, jotka ovat olleet mukanamme tähän asti, matka on ollut mahtava! Jatkathan matkamme seuraamista Hologicin Facebook-sivujen kautta Hologic

21/09/2021

We’ve been really busy over the past few months getting to know our new Hologic colleagues. As we integrate into the company, we have made the decision to stop posting on our social media channels as Mobidiag.
Thank you to all of you who have been part of our journey so far. It’s been amazing! We’d love to be able to continue to share it with you, so please follow the Hologic page.

17/06/2021

Nous sommes heureux d’annoncer le rachat de Mobidiag par Hologic, l'une des sociétés médicales les plus innovantes et leader mondial dans le domaine de la santé des femmes.

Ce rachat permettra un accès plus rapide à nos solutions sur de nouveaux marchés à l'échelle mondiale. Nous sommes ravis d’entrer dans cette nouvelle phase de développement et de croissance.

https://investors.hologic.com/press-releases/press-release-details/2021/Hologic-Completes-Acquisition-of-Mobidiag/default.aspx

17/06/2021

Olemme iloisia voidessamme kertoa, että siirrymme yrityskaupassa terveysteknologiayritys Hologic:n omistukseen.

Hologic on maailmanlaajuisesti toimiva innovatiivinen markkinajohtaja naisten terveyden alalla. Yrityskaupan ansiosta ratkaisumme pääsevät nopeammin uusille markkinoille maailmanlaajuisesti. Aloitamme nyt innoissamme uuden kasvu- ja kehitysvaiheen!

https://investors.hologic.com/press-releases/press-release-details/2021/Hologic-Completes-Acquisition-of-Mobidiag/default.aspx

17/06/2021

We are excited to announce our acquisition by Hologic, one of the world’s most innovative medical technology companies and a global champion of women’s health.

This acquisition will enable our solutions to reach new markets on a global scale and at a faster rate. We are looking forward to starting a new phase of development and growth!

https://investors.hologic.com/press-releases/press-release-details/2021/Hologic-Completes-Acquisition-of-Mobidiag/default.aspx

17/05/2021

Mobidiag headquarters is part of a dynamic and innovative life science and technology business hub at LifeScience Center at Keilaniemi area in Espoo, Finland.

Watch the latest video on how we are working here to provide sophisticated diagnostic solutions for infectious diseases and to tackle the threat of antimicrobial resistance.

https://lnkd.in/dFgHtHr

Mobidiag kehittää infektiotautidiagnostiikkaa Life Science Centerissä. "Yrityksemme on erikoistunut molekyylidiagnostiikkaan, tarjoamme ratkaisuja infektiota...

11/05/2021

Do not miss the BSMT (British Society For Microbial Technology) webinar on laboratory related aspects of COVID-19 starting today at 2pm (BST). Free registration at: https://www.bsmt.org.uk/

REGISTER HERE for the FREE BSMT Webinar on laboratory related aspects of COVID-19 (convened in conjunction with media partner Pathology in Practice).

28/04/2021

Honored to receive this year´s BioFinland Award 2021. This great recognition belongs to the whole Mobidiag team for the long-term work!

The Board of the Finnish Bioindustry Association chose Mobidiag Oy as BioFinland Award winner for its long-term work to develop Finnish technological know-how and, as an example of the Finnish Life Science company that has succeeded in fierce international competition.

27/04/2021

Interested to hear how Finnish Life Science Industry has been playing active role in COVID-19 disease control and research?

Mobidiag´s Business Development Director Kari Kataja talks tomorrow at online panel discussion organised by ChemBio Finland 2021.

Join and listen this free, virtual panel discussion on Wednesday April 28 at 10:00-11:00. More information in Finnish and pre-registrations:
https://bit.ly/2QsDyEa

Ohjelmassa muun muassa Kemian Päivien luennot, bioalan seminaarit.

08/04/2021

Mobidiag to be acquired by Hologic Inc. to accelerate global growth of Mobidiag’s differentiated molecular platform, which offers ease of use, multiplex capability and rapid turnaround time. Read full press release:

https://mobidiag.com/mobidiag-to-be-acquired-by-hologic-innovator-in-womens-health-diagnostic-testing-for-approximately-e668-million/

07/04/2021

On this World Health Day and particularly in this COVID-19 time, let's think about protective actions to keep everyone safe: washing your hands regularly, coughing/sneezing into a tissue, wearing a mask, respecting the distances.

30/03/2021

At Mobidiag, our disruptive Novodiag and Amplidiag technologies are tackling the threat of infectious diseases such as AMR and COVID-19 head on.

In his new video, our CEO Tuomas Tenkanen discusses our work and future planned projects for indications including sepsis and meningitis.

Watch now! https://youtu.be/dG6RHyJxnD8

At Mobidiag, we are committed to making a difference to patients using sophisticated and rapid diagnostic solutions. Our unique technology and knowhow allow ...

23/03/2021

Our CEO Tuomas Tenkanen explains how Mobidiag is working to provide sophisticated diagnostic solutions for infectious diseases in this new video: https://youtu.be/dG6RHyJxnD8

Tuomas describes how we are using our two technology platforms available on the market – Amplidiag and Novodiag – to tackle the threat of antimicrobial resistance, hospital-acquired infections, COVID-19 and many more significant health challenges.

Check out the video now!

At Mobidiag, we are committed to making a difference to patients using sophisticated and rapid diagnostic solutions. Our unique technology and knowhow allow ...

17/03/2021

Looking for a new and exciting career in molecular diagnostics?
We are now hiring for our R&D, Marketing, Support, Quality and Software teams. Check-out our latest job openings: https://mobidiag.com/about-us-2/careers/

01/03/2021

High-throughput molecular diagnostic test for respiratory infections, Amplidiag® RESP-4, now CE-IVD! 1 panel for 4 distinct results: SARS-CoV-2, Influenza A, Influenza B, RSV.

Learn more: https://mobidiag.com/mobidiag-receives-ce-ivd-for-amplidiag-resp-4-for-simultaneous-detection-of-covid-19-flu-a-flu-b-and-rsv/